---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-082518"
form_type: "8-K"
ticker: null
cik: "0001808865"
company_name: "iTeos Therapeutics, Inc."
filed_at: "2025-06-05T23:59:59+00:00"
generated_at: "2026-05-19T22:33:11.748770+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Board member Tim Van Hauwermeiren resigns from iTeos Therapeutics board

## Summary
- Tim Van Hauwermeiren resigned from the Board effective June 1, 2025.
- Resignation not due to any disagreement with the Company, management, or Board.
- Company has not announced a replacement for the vacant board seat.

## SEC filing metadata
- accession: 0000950170-25-082518
- form_type: 8-K
- cik: 0001808865
- company_name: iTeos Therapeutics, Inc.
- filed_at: 2025-06-05T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1808865/000095017025082518/0000950170-25-082518-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1808865/000095017025082518/itos-20250601.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-082518
- JSON: https://secwatch.observer/filing/0000950170-25-082518.json
- Plain text: https://secwatch.observer/filing/0000950170-25-082518.txt

## Key facts
- Executive change
  Tim Van Hauwermeiren resigned as Director at iTeos Therapeutics, Inc..
  - Action: resigned
  - Role: Director
  source text: On June 1, 2025, Tim Van Hauwermeiren resigned from the Board of Directors (the " Board ") of iTeos Therapeutics, Inc. (the " Company "), effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1808865/000095017025082518/0000950170-25-082518-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.